On March 16, World Health Organization (WHO) announced on its website the acceptance of GMP compliance concerning Nanhu Pharma’s antimalarial DHA/PQP production facility, after site inspection in September 2011. This is the second time Nanhu Pharma was inspected by WHO and accepted as WHO GMP compliant.
The inspection report is available from .